AB
Publicaties op Oncologisch.com
Upfront Modified FOLFOXIRI Plus Panitumumab for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Results of the...
mFOLFOXIRI plus panitumumab versus FOLFOX plus panitumumab bij RAS/BRAF-wildtype CRC: VOLFI fase II
Oligometastatisch CRC: prognose en locoregionale behandeling
Upfront FOLFOXIRI-bevacizumab en herintroductie versus mFOLFOX6-bevacizumab bij CRC: TRIBE-2 fase III